This ecological time-series study examined first tuberculosis (TB)-coded acute-care presentations in Ontario's Greater Toronto/Hamilton Area, population about 11.2 million. Data covered April 2011 to March 2024, with nontuberculous mycobacterial (NTM) presentations as a comparator. Models related weekly SARS-CoV-2, influenza and RSV activity to presentations over the following 0 to 12 weeks. Among 3,985 TB presentations, the estimated pandemic-era rise was 3% to 22%, while NTM did not rise. The TB rate ratio per 1-SD rise in SARS-CoV-2 activity was 0.909 (95% CI 0.822 to 1.006). The design is ecological, and the size of the TB rise depended on assumed underlying trends.
Why it is interesting: Immune dysfunction after SARS-CoV-2 infection has been proposed as one driver of rising TB in high-income countries. This population analysis found no positive association, even with follow-up windows extended to 52 weeks.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.